CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis. Reply.

N Engl J Med

Intellia Therapeutics, Cambridge, MA.

Published: October 2021

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc2114592DOI Listing

Publication Analysis

Top Keywords

crispr-cas9 vivo
4
vivo gene
4
gene editing
4
editing transthyretin
4
transthyretin amyloidosis
4
amyloidosis reply
4
crispr-cas9
1
gene
1
editing
1
transthyretin
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!